Outcomes of Endoscopic Congenital Cholesteatoma Removal in South Korea

Author:

Choi Ji Eun1,Kang Woo Seok2,Lee Jong Dae3,Chung Jong Woo2,Kong Soo-Keun4,Lee Il-Woo5,Moon Il Joon6,Hur Dong Gu7,Moon In Seok8,Cho Hyong Ho9

Affiliation:

1. Department of Otorhinolaryngology–Head and Neck Surgery, Dankook University Hospital, Cheonan, South Korea

2. Department of Otorhinolaryngology–Head & Neck Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

3. Department of Otorhinolaryngology–Head and Neck Surgery, Soonchunhyang University College of Medicine, Bucheon, South Korea

4. Department of Otorhinolaryngology–Head and Neck Surgery, Pusan National University School of Medicine, Pusan National University Hospital, Busan, South Korea

5. Department of Otorhinolaryngology–Head and Neck Surgery, Pusan National University School of Medicine, Pusan National University Yangsan Hospital, Yangsan, South Korea

6. Department of Otorhinolaryngology–Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

7. Department of Otorhinolaryngology, Gyeongsang National University Changwon Hospital, College of medicine, Gyeongsang National University, Changwon, South Korea

8. Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, South Korea

9. Department of Otolaryngology–Head and Neck Surgery, Chonnam National University Medical School, Gwangju, South Korea

Abstract

ImportanceTranscanal endoscopic ear surgery (TEES) provides minimally invasive transcanal access to the middle ear and improves middle ear visibility during cholesteatoma resection. However, the literature on outcomes following TEES alone for the removal of congenital cholesteatoma (CC) is lacking and limited to small series.ObjectiveTo assess outcomes of TEES for CC limited to the middle ear and/or mastoid antrum and to explore the risk factors associated with recidivism (ie, recurrent and/or residual cholesteatoma).Design, Setting, and ParticipantsThis cohort study evaluated retrospective, multicenter data for 271 children with CC who underwent TEES at 9 tertiary referral hospitals in South Korea between January 1, 2013, and December 31, 2021, and had a follow-up of at least 6 months after surgery.Main Outcomes and MeasuresOutcomes included the incidence of residual cholesteatoma and audiometric data after TEES. A multivariable analysis using Cox proportional hazards regression models was used to assess associations between cholesteatoma characteristics and recidivism, with hazard ratios (HRs) and 95% CIs reported.ResultsOf the 271 patients (mean [SD] age, 3.5 [2.9] years; 194 [71.6%] boys, 77 [28.4%] girls), 190 had Potsic stage I CC (70.1%), 21 (7.7%) had stage II, 57 (21.0%) had stage III, and 3 (1.1%) had stage IV. Thirty-six patients (13.3%) with residual cholesteatoma were found, including 15 (7.9%) with Potsic stage I, 3 (14.3%) with stage II, and 18 (31.6%) with stage III. In the multivariable analysis, invasion of the malleus (HR, 2.257; 95% CI, 1.074-4.743) and posterosuperior quadrant location (HR, 3.078; 95% CI, 1.540-6.151) were associated with the incidence of recidivism. Overall, hearing loss (>25 dB on auditory behavioral test or >30 dB of auditory evoked responses) decreased from 24.4% to 17.7% after TEES.Conclusions and RelevanceThis cohort study involved the largest known population to date of CC removed by TEES. The findings suggest that TEES may be feasible and effective for the removal of CC limited to the middle ear and/or mastoid antrum in children.

Publisher

American Medical Association (AMA)

Subject

Otorhinolaryngology,Surgery

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3